GlassScriptPhysician profile
Gerald Q Greenfield
NPI 1457393316
$3,899.96
in general payments reported to CMS, 2019-2025
26 companies · $1,213 in 2025
The $1,213 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $235 · 2020: $112 · 2021: $749 · 2022: $530 · 2023: $333 · 2024: $728 · 2025: $1,213.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,589 · Travel and Lodging: $684.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,589.29 |
| Travel and Lodging | $684.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $794.26 | 2025 | Attune |
| Depuy Synthes Sales INC. | $574.38 | 2020-2025 | Tfn-Advance, Na, Lcp |
| Zimmer Biomet Holdings, INC. | $274.51 | 2021-2025 | Persona |
| Medtronic, INC. | $259.67 | 2022-2023 | Prestige LP Cervical Disc System |
| Orthofix Medical, INC. | $184.27 | 2019-2025 | Physio-Stim, Cervical-Stim |
| Sanara Medtech INC. | $164.37 | 2024 | Celleraterx |
| Si-Bone, INC. | $149.97 | 2021-2022 | |
| Globus Medical, INC. | $149.59 | 2022 | |
| Mission Medical Distribution, LLC | $148.13 | 2024 | |
| Pacira Therapeutics, INC. | $148.11 | 2019-2021 | |
| Bone Support INC. | $137.90 | 2021 | |
| Heron Therapeutics, INC. | $131.66 | 2024 | Aponvie, Zynrelef |
| Vericel Corporation | $121.91 | 2021 | |
| Acumed LLC | $111.05 | 2025 | Acumed |
| Abbott Laboratories | $110.50 | 2019-2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $105.75 | 2023 | Prevena, V.A.C.Ulta |
| Medartis INC. | $104.43 | 2023 | Aptus |
| Smith+Nephew, INC. | $60.41 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $28.09 | 2025 | |
| Amgen INC. | $27.37 | 2019-2022 | |
| Djo, LLC | $25.87 | 2021 | |
| Relievant Medsystems, INC. | $21.65 | 2021 | |
| Prosidyan, INC | $18.70 | 2021 | |
| Davol INC. | $16.60 | 2022 | |
| Scilex Pharmaceuticals INC. | $16.21 | 2022 | |
| Medacta USA, INC. | $14.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerald Greenfield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.